FFA
EW icon

Frazier Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Frazier Financial Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Hold
1,278
– – 0.06% 112
2026
Q1 		$102K Sell
1,278
-124
-9% -$10.2K 0.06% 115
2025
Q4 		$120K Buy
1,402
+124
+10% +$10.2K 0.07% 95
2025
Q3 		$99.4K Hold
1,278
– – 0.06% 102
2025
Q2 		$100K Sell
1,278
-24
-2% -$1.79K 0.07% 99
2025
Q1 		$94.4K Hold
1,302
– – 0.07% 90
2024
Q4 		$96.7K Buy
1,302
+30
+2% +$2.1K 0.08% 87
2024
Q3 		$83.9K Hold
1,272
– – 0.07% 101
2024
Q2 		$117K Sell
1,272
-43
-3% -$3.81K 0.09% 88
2024
Q1 		$126K Sell
1,315
-115
-8% -$9.66K 0.1% 85
2023
Q4 		$109K Buy
+1,430
New +$99.5K 0.09% 82

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Frazier Financial Advisors's EW Position: Q2 2026 in Review

Frazier Financial Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,278 shares worth $116K. The position accounts for 0.06% of the portfolio, ranked #112.

Frazier Financial Advisors first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $126K in Q1 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Frazier Financial Advisors held 1,278 shares of Edwards Lifesciences worth $116K as of Q2 2026.
  • Frazier Financial Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.06% of Frazier Financial Advisors's portfolio in Q2 2026, its #112 holding.
  • Frazier Financial Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Edwards Lifesciences position peaked at $126K in Q1 2024.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.